慶應義塾大学ヒト生物学-微生物叢-量子計算研究センター（WPI-Bio2Q）は、以下のとおり、公開セミナーを開催しました。

講演要旨

RNA molecules frequently undergo post-transcriptional modifications, which are essential for their proper function. To date, about 150 different types of chemical modifications have been identified in various RNA molecules across all domains of life. There are still a number of novel modifications to be discovered. RNA modifications appear to confer chemical diversities to simple RNA molecules basically composed of four letters, to acquire a greater variety of biological functions. These modifications play critical roles in stability and functions of RNA molecules. The physiological importance of RNA modification has been demonstrated by human diseases caused by aberrant RNA modification. We reported a severe reduction in the frequency of tRNA modifications in mitochondrial disease patients, like MELAS and MERRF. These findings provided the first evidence of RNA modification disorder. We have termed “RNA modopathy” as a new category of human diseases.

Queuosine (Q), a tRNA modification characterized by a 7-deazaguanosine with a bulky side chain, is widely present in both bacteria and eukaryotes. Unique to this modification, the free base of Q, known as queuine, is incorporated through a base replacement reaction, converting guanine (G) to Q. Eukaryotes, including humans, cannot synthesize queuine and must obtain it as a dietary nutrient from gut microbiota or dietary sources. In humans and other vertebrates, Q can be further modified by glycosylation, forming either galactosyl-queuosine (galQ) or mannosyl-queuosine (manQ). The function of these glycosylated Q modifications remained unclear for nearly half a century after their discovery. Recently, we identified two glycosyltransferases responsible for the formation of galQ and manQ and elucidated the biosynthesis, functional roles in protein synthesis, and physiological significance of these glycosylated Q tRNA modifications.